Company intelligence / Profile preview

Beijing Huasheng Pharmaceutical

Beijing, Beijing, China

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Beijing Huasheng Pharmaceutical is a China-based pharmaceutical company primarily focused on the research, development, and manufacturing of psychiatric and neurological medications. The company operates a significant R&D facility known as the Beijing Huasheng Drug Research Institute, which specializes in the synthesis and formulation of complex small molecule drugs. Their product portfolio includes treatments for schizophrenia, depression, and sleep disorders, with several generic and innovative products reaching the Chinese market. Huasheng is recognized for its integration of drug discovery with large-scale GMP manufacturing capabilities.

Therapeutic areas: Psychiatry
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Beijing Huasheng Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Huasheng Pharmaceutical.

Explore the full profile